Baiyun Mountain Giant Earthquake: Commercial bribery behind the price of virtual lifting of the drug price

Economic Observer reporter Zhang Xiaohui 87 medicines, 5 years.

On August 9, 2022, Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. (600332.SH, hereinafter referred to as "Baiyunshan") revealed the "virtual lifting price" incident.

After the news was revealed, Baiyunshan's stock price plummeted. On August 10, the stock opened low and opened at 27.4 yuan per share. Yuan.

Behind the "virtual lifting price" is a bribery case frequently in the pharmaceutical industry.

Virtual lifting price

It was the National Medical Security Bureau (hereinafter referred to as the "National Medical Insurance Bureau").

On August 9, 2022, the State Medical Insurance Bureau issued the "Notice on the Price of Three Enterprises such as Tianxin Pharmaceuticals and the Price Price Price Case Related Fund" (hereinafter referred to as the "Notice").

According to the "Notice", recently, the National Medical Insurance Bureau, in accordance with relevant departments, guides relevant provinces to Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (hereinafter referred to as "Tianxin Pharmaceutical"), Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. Baiyunshan Pharmaceuticals The three companies including the General Factory (hereinafter referred to as the "Baiyunshan Pharmaceutical General Plant"), Guangzhou Baiyunshan Jingxiu Pharmaceutical Co., Ltd. (hereinafter referred to as "Jingxiu Tang Pharmaceutical") investigation.

The above three companies are subsidiaries of Baiyun Mountain.

The National Medical Insurance Bureau found that from May 2017 to May 2021, three pharmaceutical manufacturers including Tianxin Pharmaceuticals were in order to avoid the "two -vote system" policies and supervision, and they colluded with more than 50 pharmaceutical agents in the lower reaches, and the injection was used. The 87 kinds of drugs were cash out by the way to purchase raw medicines in virtual high -priced prices, and transferred funds to downstream drug agents. The amount involves huge amounts, and some of them are used for bribery medical staff or specific relationship persons to carry out drug violations.

The main operation method of cash out is that pharmaceutical manufacturers signed a cooperation agreement with drug agents to increase the designated "dealers" in the procurement of the raw and drug. Double -fold sales to drug manufacturers. Pharmaceutical manufacturers further transmit the virtual high price of raw drugs to the price of factory and bidding network prices in the name of "raising price increases and high production costs". The "dealer" of the raw medicine "dealer" is actually controlled by the drug agent, and the difference in income obtained by the low -selling and high -sale and high -sale raw medicines is cash to the drug agent for medical business bribery.

The "Notice" states that taking cephalosporin sulfur sulfur as an example, Baiyunshan Pharmaceutical (Preparation Factory) and Baiyunshan Chemical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceut The purchase of raw materials, but an additional cash -up process, which is transferred by the agent's raw medicine "dealer", sells low to the preparation factory and cash out. The preparation factory uses the high price of cephalosporin sulfurizer in the cost of the raw medicine drug, which makes the drug production and circulation link on the surface and other policies and regulations to avoid supervision.

At present, three enterprises such as Tianxin Pharmaceuticals have rectified 87 kinds of drugs such as cephalosporin sulfurizes across the country as required and eliminated the virtual heights such as bribery in the current price. The product regulations were stopped purchased. Guangdong Province ordered three companies including Tianxin Pharmaceutical and other related companies to comprehensively rectify marketing models to stop relevant illegal operations. In addition, relevant departments are investigating and punishing in accordance with the law for those suspected of disciplinary, illegal, and crimes.

The "two -vote system" mentioned in the "Notice" refers to the purchase of the drug from the pharmaceutical factory to the first -level dealer to issue an invoice. Eight votes, reducing the layers of circulation links, and the first -level dealers of each variety must not exceed 2.

In January 2017, a notification issued by the State Council's Medical Reform Office, together with the National Health and Family Planning Commission, etc., was clearly issued by the 8 departments of the National Health and Family Planning Commission. Public medical institutions in the pilot provinces (autonomous regions, municipalities) and public hospital reform pilot cities must take the lead in promoting drug procurement " "Two -vote system" encourages other regions to implement the "two -vote system" in order to further reduce the price of drugs and reduce the burden on the masses.

The list of medicines "not within the scope of disclosure"

On August 10, 2022, Bai Yunshan issued an announcement in response to the "virtual lifting price" incident.

Bai Yunshan mainly expressed two points in the announcement announcement:

First, in 2021, the above three companies involved the gross profit of the withdrawal of the net products was RMB 1.15 million, and the gross profit reduction of prices was RMB 320 million, accounting for the company's 2021 gross profit ratio of 0.12%and 2.45%; 2022; 2022 From January to March of the year, the three companies involved the gross profit of the withdrawal of the net products was RMB 122 million, and the gross profit reduction of prices was RMB 102 million, accounting for the company's unveiled gross profit amount from January to March 2022, respectively. 0.25%, 2.13%. It is expected that this matter will have a certain impact on the company's future product sales, but it will not have a significant impact on the company's operating performance.

Second, the company attaches great importance to this report and has taken a series of rectification measures. The three companies have been instructed to stop cooperation with relevant agents and dealers, comprehensively rectify the marketing model, and carry out related products to reduce prices or withdraw from the Internet across the country. Responsible persons are exempt from office suspension. A reporter from the Economic Observer called Bai Yunshan's Office of Secretary, hoping to obtain a list of 87 medicines, and the names of the three companies being dismissed. Bai Yunshan's office replied that this part of the information was not within the scope of disclosure.

Some investors expressed their questions.

On the SSE E -interactive platform, some investors asked: "Is your company punished by the Medical Insurance Bureau, because some time ago, the company's discussing the medical insurance bureau's collection and reporting high prices in the collection of medical insurance bureaus?"

Bai Yunshan has not returned to investors.

Pharmaceutical companies are exclusive in the market, or drugs have a large market share, then pharmaceutical companies have a high right to speak, which can easily affect the upstream and downstream links of the drug.

For the currently disclosed injection of cephalosporin sulfur, Baiyunshan has a large market share. The injection of the cephalosporin produced by Tianxin Pharmaceuticals is the "Aweixin" brand. With the "Xianlisan" brand, the antibiotic medicine, the cephalosporin series, is the second largest variety of Baiyun Mountain, with annual revenue of 915 million yuan.

If a drug and a pharmaceutical company, the "virtual lifting price" occurred in an occasional incident, then the three pharmaceutical companies that belong to Bai Yunshan, 87 medicines, and the "virtual lifting price" incident for 5 years are obviously no longer no longer accidental.

Pharmaceuticals

The National Medical Insurance Administration pointed out the key in the "Notice "-" 87 kinds of drugs are cash out by using virtual high -priced prices and transferred funds to downstream drug agents. Medical staff or specific relationships, carry out drug violations. "

The reporter searched the referee document network found that some grass -roots medical personnel and medical representatives colluded and collected rebates in the process of selling the drugs of the above three companies.

On October 20, 2014, the judgment of Luo Zhaoxing, the dean of the Wenheng Town Health Center of Liancheng County ([2014] No. 205 of Lianxin Chu), from the former Liancheng County Hengheng Town Health Center, from 2010 to February 2013, The defendant Luo Zhaoxing received a reckless deduction of pharmaceutical representative Wu Moujia during the president of the Central Health Center of Mustea Town, Liancheng County, including the injecting of Sisiidin sodium (2 grams per bottle) per bottle of 2 yuan per bottle for injection of Tianxin Pharmaceutical. Essence

Another judgment ([2015] No. 35 of Lian Xingjuzi) of Liancheng County People's Court mentioned that Ma Mou, the former dean of the Sibao Health Center of Liancheng County, purchased Cosmotin from 2010 to 2013 ( In the process of Tianxin Pharmaceutical), the rebate is charged illegally in accordance with the standard of each 1 yuan.

In addition, there are multiple judgments mentioned:

From 2011 to 2013, Li Fang Township Health Center, former Liancheng County, was collected in accordance with the standard of 3 yuan per bottle in the process of purchasing the cephalosporin (2G) process produced by Tianxin Pharmaceutical.

From 2011 to December 2011, Huang Moujia, the head of the pharmacy and director of Wenheng Town Health Center in Liancheng County, purchased the cephalia sodium produced by Tianxin Pharmaceutical Co., Ltd. (1g per bottle, and the unit price is per bottle. In the process of 22.8 yuan), 1,800 yuan was received by Jiang's bribery, respectively, and 7,200 yuan for the drug rebate from the original pharmacy group of the North Regiment Health Center, a total of 9,000 yuan.

A judgment of the Shanghang County People's Court in Fujian showed that from May 2012 to March 2014, Chen Kaiyao, the former dean of the Chadi Township Health Center of Shanghang County, sent a total of 2,000 Bottle cosmidin sodium (production of Tianxin Pharmaceutical), Chen Kaiyao charged drug rebates in accordance with the standard of 6 yuan/bottle.

Sodium custard sodium produced by Tianxin Pharmaceutical is a variety of high -incidence of grass -roots pharmaceutical personnel.

Cef sulfurite named the State Medical Insurance Bureau was used as an example. The referee document network showed that many bribery cases have occurred.

In October 2018, the judgment of Tan Wei, director of the former Jiangxi Provincial Maternal and Child Health Hospital of Nanchang Intermediate Court of Jiangxi Province, mentioned that in early 2013, Cai Mou, the sales manager of Binjiang Pharmaceutical Company, found Tan Wei It is hoped that Tan Wei will take care of the cephalosporin drugs represented by Binjiang Pharmaceutical Company's injection of Binjiang Pharmaceutical Company, and promise to return to Tan Wei at a standard of 3 yuan/branch. Tan Wei agrees.

Binjiang Pharmaceutical Company has been in injection of cephalosporin sulfur (0.5g, Baiyunshan Pharmaceutical Production) from the Jiangxi Provincial Maternal and Child Health Hospital on November 28, 2012. From January 2013 to December 2014 16,795 medicines (the number of each month is detailed).

Because Bai Yunshan does not disclose more detailed cases of drugs, drug dealers, and personnel related responsible persons involved in the case, it is difficult to presented to the public. The cover of the three subsidiaries of Baiyunshan's subsidiaries of "Protecting Medicine Price" also sounded the alarm for other pharmaceutical companies.

- END -